by admin | Mar 26, 2013 | Uncategorized
Eritoran, a promising first-in-class agent for combating Gram-negative sepsis, failed its Phase 3 clinical trial, according to the results of the ACCESS trial published in the March 20th issue of JAMA. Eritoran is synthetic lipid A antagonist that blocks...
by admin | Mar 20, 2013 | Uncategorized
Early antibiotic administration is a critical step in appropriate sepsis care. However, overuse and misuse of antibiotics, including the unnecessarily prolonged use of antibiotics, can have adverse effects and lead to increased microbial resistance. A Comparative...
by admin | Jan 31, 2013 | Medical
The much anticipated 2012 Surviving Sepsis Campaign guidelines were released at the annual Society of Critical Care Medicine congress in San Juan, Puerto Rico. The new guidelines are published in the February 2013 issue of Critical Care Medicine (CCM 2013;41(2):580)...
by admin | Jan 14, 2013 | Medical
An update of the 2008 Surviving Sepsis Campaign (SSC) guidelines is expected in the early part of 2013. Key elements of this update were previewed at the 2012 meetings of the Society of Critical Care Medicine (SCCM) and the American College of Emergency Physicians...
by admin | Jan 10, 2013 | Medical, Regulatory
In a proposal released with the 2013 State of the State address, New York state Governor Andrew Cuomo called for the statewide establishment of standardized, evidence-based protocols to facilitate rapid and accurate diagnosis and treatment of sepsis in all New York...
